交易 Abbvie - ABBV CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.66 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.030779% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | -0.013666% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Abbvie Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 145.08 | 0.04 | 0.03% | 145.04 | 146.64 | 144.53 |
Feb 2, 2023 | 144.58 | -0.57 | -0.39% | 145.15 | 145.42 | 143.25 |
Feb 1, 2023 | 146.42 | 0.55 | 0.38% | 145.87 | 147.28 | 144.87 |
Jan 31, 2023 | 147.60 | 2.08 | 1.43% | 145.52 | 147.69 | 144.20 |
Jan 30, 2023 | 145.53 | 0.04 | 0.03% | 145.49 | 146.97 | 144.87 |
Jan 27, 2023 | 146.10 | -0.85 | -0.58% | 146.95 | 147.39 | 145.87 |
Jan 26, 2023 | 146.87 | -0.30 | -0.20% | 147.17 | 148.53 | 146.87 |
Jan 25, 2023 | 147.65 | 1.63 | 1.12% | 146.02 | 147.72 | 146.02 |
Jan 24, 2023 | 147.16 | -0.41 | -0.28% | 147.57 | 148.55 | 146.25 |
Jan 23, 2023 | 147.93 | -1.63 | -1.09% | 149.56 | 149.74 | 147.90 |
Jan 20, 2023 | 149.52 | 1.45 | 0.98% | 148.07 | 149.57 | 146.87 |
Jan 19, 2023 | 148.50 | 0.32 | 0.22% | 148.18 | 150.37 | 147.10 |
Jan 18, 2023 | 149.01 | -2.52 | -1.66% | 151.53 | 152.26 | 148.63 |
Jan 17, 2023 | 152.50 | -0.59 | -0.39% | 153.09 | 154.93 | 152.24 |
Jan 13, 2023 | 153.47 | 1.61 | 1.06% | 151.86 | 153.67 | 151.30 |
Jan 12, 2023 | 151.67 | -3.04 | -1.96% | 154.71 | 154.95 | 151.50 |
Jan 11, 2023 | 156.65 | -2.32 | -1.46% | 158.97 | 158.97 | 154.86 |
Jan 10, 2023 | 159.46 | -2.40 | -1.48% | 161.86 | 162.23 | 158.13 |
Jan 9, 2023 | 161.43 | -3.37 | -2.04% | 164.80 | 166.05 | 160.72 |
Jan 6, 2023 | 166.40 | 3.13 | 1.92% | 163.27 | 167.95 | 163.27 |
Abbvie Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
总收入 | 25638 | 28216 | 32753 | 33266 | 45804 | 56197 |
收入 | 25638 | 28216 | 32753 | 33266 | 45804 | 56197 |
收入成本,共计 | 5814 | 7158 | 7557 | 7606 | 15257 | 17314 |
毛利 | 19824 | 21058 | 25196 | 25660 | 30547 | 38883 |
总营业费用 | 16254 | 18624 | 26370 | 20283 | 34441 | 38273 |
销售/一般/行政费用,总计 | 5855 | 6275 | 7399 | 6942 | 11299 | 11996 |
研究与开发 | 4366 | 4982 | 5229 | 5407 | 6181 | 6982 |
利息费用(收入) - 净运营 | -20 | -118 | 161 | -167 | ||
异常费用(收入) | 239 | 327 | 5524 | 505 | 1704 | 1549 |
Other Operating Expenses, Total | 0 | 500 | -10 | 0 | 432 | |
营业收入 | 9384 | 9592 | 6383 | 12983 | 11363 | 17924 |
利息收入(费用),非经营净值 | -1268 | -1442 | -1168 | -1551 | -2351 | -2435 |
其他,净值 | -232 | -423 | -18 | -3006 | -5614 | -2500 |
税前净收入 | 7884 | 7727 | 5197 | 8426 | 3398 | 12989 |
税后净收入 | 5953 | 5709 | 5773 | 7882 | 4622 | 11549 |
未计算非常项目前的净收益 | 5953 | 5709 | 5773 | 7882 | 4616 | 11542 |
净收入 | 5953 | 5309 | 5687 | 7882 | 4616 | 11542 |
Total Adjustments to Net Income | -30 | -26 | -30 | -40 | -60 | -74 |
普通股股东可获收益 (不含非经常性项目) | 5923 | 5683 | 5743 | 7842 | 4556 | 11468 |
普通股股东可获收益 (含非經常性項目) | 5923 | 5283 | 5657 | 7842 | 4556 | 11468 |
摊薄净收入 | 5923 | 5283 | 5657 | 7842 | 4556 | 11468 |
摊薄后加权平均股 | 1631 | 1603 | 1546 | 1484 | 1673 | 1777 |
扣除特别项目的每股摊薄盈利 | 3.63151 | 3.54523 | 3.71475 | 5.28437 | 2.72325 | 6.45357 |
Dividends per Share - Common Stock Primary Issue | 2.28 | 2.56 | 3.59 | 4.28 | 4.72 | 5.2 |
每股正常摊薄盈利 | 3.77219 | 3.94326 | 6.27662 | 5.75749 | 3.65923 | 7.31817 |
非常规项目总计 | -400 | -86 | ||||
少数股东权益 | -6 | -7 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
总收入 | 13010 | 13959 | 14342 | 14886 | 13538 |
收入 | 13010 | 13959 | 14342 | 14886 | 13538 |
收入成本,共计 | 4192 | 4498 | 4344 | 4280 | 4021 |
毛利 | 8818 | 9461 | 9998 | 10606 | 9517 |
总营业费用 | 8907 | 9518 | 10036 | 9812 | 8821 |
销售/一般/行政费用,总计 | 2775 | 3077 | 2977 | 3167 | 3057 |
研究与开发 | 1731 | 1784 | 1655 | 1812 | 1488 |
异常费用(收入) | 209 | 227 | 560 | 553 | 255 |
Other Operating Expenses, Total | 0 | -68 | 500 | 0 | |
营业收入 | 4103 | 4441 | 4306 | 5074 | 4717 |
利息收入(费用),非经营净值 | -631 | -620 | -597 | -587 | -564 |
其他,净值 | 395 | -2658 | -21 | -216 | 776 |
税前净收入 | 3867 | 1163 | 3688 | 4271 | 4929 |
税后净收入 | 3555 | 769 | 3180 | 4045 | 4493 |
少数股东权益 | -2 | -3 | -1 | -1 | -3 |
未计算非常项目前的净收益 | 3553 | 766 | 3179 | 4044 | 4490 |
净收入 | 3553 | 766 | 3179 | 4044 | 4490 |
Total Adjustments to Net Income | -17 | -17 | -21 | -21 | -22 |
普通股股东可获收益 (不含非经常性项目) | 3536 | 749 | 3158 | 4023 | 4468 |
普通股股东可获收益 (含非經常性項目) | 3536 | 749 | 3158 | 4023 | 4468 |
摊薄净收入 | 3536 | 749 | 3158 | 4023 | 4468 |
摊薄后加权平均股 | 1776 | 1776 | 1777 | 1780 | 1778 |
扣除特别项目的每股摊薄盈利 | 1.99099 | 0.42173 | 1.77715 | 2.26011 | 2.51294 |
Dividends per Share - Common Stock Primary Issue | 1.3 | 1.3 | 1.3 | 1.3 | 1.41 |
每股正常摊薄盈利 | 2.12203 | 0.52661 | 2.08542 | 2.56798 | 2.68011 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
流动资产总额 | 16187 | 21223 | 16945 | 49519 | 24173 | 27928 |
现金和短期投资 | 6423 | 9789 | 8061 | 39924 | 8479 | 9830 |
现金等价物 | 5100 | 9303 | 7289 | 39924 | 8449 | 9746 |
短期投资 | 1323 | 486 | 772 | 0 | 30 | 84 |
应收账款总额,净额 | 4758 | 5088 | 5384 | 5428 | 8822 | 9977 |
Accounts Receivable - Trade, Net | 4758 | 5088 | 5384 | 5428 | 8822 | 9977 |
Total Inventory | 1444 | 1605 | 1605 | 1813 | 3310 | 3128 |
Prepaid Expenses | 3337 | 4718 | 1763 | 2332 | 3562 | 4993 |
Other Current Assets, Total | 225 | 23 | 132 | 22 | ||
Total Assets | 66099 | 70786 | 59352 | 89115 | 150565 | 146529 |
Property/Plant/Equipment, Total - Net | 2604 | 2803 | 2883 | 3306 | 6143 | 5872 |
Property/Plant/Equipment, Total - Gross | 7526 | 8071 | 8396 | 8532 | 11754 | 11489 |
Accumulated Depreciation, Total | -4922 | -5268 | -5513 | -5226 | -5611 | -5617 |
Goodwill, Net | 15416 | 15785 | 15663 | 15604 | 33124 | 32379 |
Intangibles, Net | 28897 | 27559 | 21233 | 18649 | 82876 | 75951 |
Long Term Investments | 1783 | 2090 | 1420 | 93 | 293 | 277 |
Other Long Term Assets, Total | 1212 | 1326 | 1208 | 1944 | 3956 | 4122 |
Total Current Liabilities | 9781 | 16641 | 17239 | 15585 | 28661 | 35194 |
Accounts Payable | 1407 | 1474 | 1546 | 1452 | 2276 | 2882 |
Payable/Accrued | 3375 | 3628 | 4026 | 3128 | 6516 | 7057 |
Accrued Expenses | 3531 | 3832 | 4726 | 5423 | 9032 | 10217 |
Notes Payable/Short Term Debt | 377 | 400 | 3699 | 0 | 34 | 14 |
Current Port. of LT Debt/Capital Leases | 25 | 6015 | 1609 | 3753 | 8468 | 12481 |
Other Current Liabilities, Total | 1066 | 1292 | 1633 | 1829 | 2335 | 2543 |
Total Liabilities | 61463 | 65689 | 67798 | 97287 | 137489 | 131121 |
Total Long Term Debt | 36440 | 30953 | 35002 | 62975 | 77554 | 64189 |
Long Term Debt | 36440 | 30953 | 35002 | 62955 | 77533 | 64164 |
Deferred Income Tax | 6890 | 2490 | 1067 | 1130 | 3646 | 3009 |
Other Liabilities, Total | 8352 | 15605 | 14490 | 17597 | 27607 | 28701 |
Total Equity | 4636 | 5097 | -8446 | -8172 | 13076 | 15408 |
Common Stock | 18 | 18 | 18 | 18 | 18 | 18 |
Additional Paid-In Capital | 13678 | 14270 | 14756 | 15193 | 17384 | 18305 |
Retained Earnings (Accumulated Deficit) | 4378 | 5459 | 3368 | 4717 | 1055 | 3127 |
Treasury Stock - Common | -10852 | -11923 | -24108 | -24504 | -2264 | -3143 |
Unrealized Gain (Loss) | 46 | 0 | -10 | 0 | 0 | |
Other Equity, Total | -2632 | -2727 | -2470 | -3596 | -3117 | -2899 |
Total Liabilities & Shareholders’ Equity | 66099 | 70786 | 59352 | 89115 | 150565 | 146529 |
Total Common Shares Outstanding | 1592.51 | 1592.13 | 1478.82 | 1478.91 | 1765.13 | 1768.34 |
Capital Lease Obligations | 20 | 21 | 25 | |||
Minority Interest | 21 | 28 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 26569 | 25999 | 28957 | 27928 | 26509 |
现金和短期投资 | 9777 | 8600 | 12249 | 9830 | 7572 |
现金等价物 | 9755 | 8546 | 12182 | 9746 | 6098 |
短期投资 | 22 | 54 | 67 | 84 | 1474 |
应收账款总额,净额 | 9588 | 9914 | 9281 | 9977 | 10733 |
Accounts Receivable - Trade, Net | 9588 | 9914 | 9281 | 9977 | 10733 |
Total Inventory | 3272 | 3386 | 3094 | 3128 | 3483 |
Prepaid Expenses | 3932 | 4099 | 4333 | 4993 | 4721 |
Total Assets | 150501 | 147972 | 148858 | 146529 | 143211 |
Property/Plant/Equipment, Total - Net | 5193 | 5161 | 5130 | 5872 | 5075 |
Property/Plant/Equipment, Total - Gross | 10887 | 10816 | 10803 | 10727 | 10879 |
Accumulated Depreciation, Total | -5694 | -5655 | -5673 | -5617 | -5804 |
Goodwill, Net | 32349 | 32398 | 32296 | 32379 | 32298 |
Intangibles, Net | 81293 | 79340 | 77456 | 75951 | 73986 |
Long Term Investments | 305 | 266 | 272 | 277 | 260 |
Other Long Term Assets, Total | 4792 | 4808 | 4747 | 4122 | 5083 |
Total Current Liabilities | 31951 | 28684 | 28533 | 35194 | 32521 |
Payable/Accrued | 20604 | 20783 | 21861 | 22699 | 22569 |
Notes Payable/Short Term Debt | 9 | 17 | 16 | 14 | 12 |
Current Port. of LT Debt/Capital Leases | 11338 | 7884 | 6656 | 12481 | 9940 |
Total Liabilities | 136791 | 135403 | 135308 | 131121 | 126928 |
Total Long Term Debt | 74183 | 74237 | 74049 | 64189 | 63522 |
Long Term Debt | 74183 | 74237 | 74049 | 64164 | 63522 |
Deferred Income Tax | 3768 | 3661 | 3602 | 3009 | 2831 |
Minority Interest | 23 | 25 | 27 | 28 | 31 |
Other Liabilities, Total | 26866 | 28796 | 29097 | 28701 | 28023 |
Total Equity | 13710 | 12569 | 13550 | 15408 | 16283 |
Common Stock | 18 | 18 | 18 | 18 | 18 |
Additional Paid-In Capital | 17712 | 17936 | 18108 | 18305 | 18731 |
Retained Earnings (Accumulated Deficit) | 2292 | 740 | 1600 | 3127 | 5103 |
Treasury Stock - Common | -3017 | -3022 | -3020 | -3143 | -4585 |
Other Equity, Total | -3295 | -3103 | -3156 | -2899 | -2984 |
Total Liabilities & Shareholders’ Equity | 150501 | 147972 | 148858 | 146529 | 143211 |
Total Common Shares Outstanding | 1765.66 | 1767.03 | 1767.81 | 1768.34 | 1766.87 |
Capital Lease Obligations | 25 |
- 年度
- 每季度
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
净收入/起跑线 | 5953 | 5309 | 5687 | 7882 | 4622 | 11549 |
经营活动产生的现金 | 7041 | 9960 | 13427 | 13324 | 17588 | 22777 |
经营活动产生的现金 | 425 | 425 | 471 | 464 | 666 | 803 |
Amortization | 764 | 1076 | 1294 | 1553 | 5805 | 7718 |
非现金物品 | 1588 | 3141 | 7101 | 4754 | 8714 | 4927 |
Cash Taxes Paid | 3563 | 1696 | 35 | 1447 | 1674 | 3648 |
已付现金利息 | 986 | 1099 | 1215 | 1794 | 2619 | 2712 |
营运资金的变化 | -1689 | 9 | -1126 | -1329 | 106 | -1322 |
投资活动产生的现金 | -6074 | -274 | -1006 | 596 | -37557 | -2344 |
资本支出 | -479 | -529 | -638 | -552 | -798 | -787 |
其他投资现金流量项目,总计 | -5595 | 255 | -368 | 1148 | -36759 | -1557 |
融资活动产生的现金 | -3928 | -5512 | -14396 | 18708 | -11501 | -19039 |
融资现金流项目 | -34 | -246 | -104 | -552 | -333 | -674 |
Total Cash Dividends Paid | -3717 | -4107 | -5580 | -6366 | -7716 | -9261 |
股票的发行(报废),净额 | -5765 | -1156 | -11941 | -621 | -769 | -690 |
债务的发行(退还),净额 | 5588 | -3 | 3229 | 26247 | -2683 | -8414 |
外汇效应 | -338 | 29 | -39 | 7 | -5 | -97 |
现金净变化 | -3299 | 4203 | -2014 | 32635 | -31475 | 1297 |
Deferred Taxes | -2325 | -898 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 3555 | 4324 | 7504 | 11549 | 4493 |
Cash From Operating Activities | 4877 | 9767 | 17702 | 22777 | 4908 |
Cash From Operating Activities | 206 | 407 | 630 | 803 | 198 |
Amortization | 2009 | 4008 | 5912 | 7718 | 1855 |
Deferred Taxes | -28 | -119 | -153 | -898 | -194 |
Non-Cash Items | 91 | 3093 | 4047 | 4927 | -169 |
Changes in Working Capital | -956 | -1946 | -238 | -1322 | -1275 |
Cash From Investing Activities | -342 | -584 | -1199 | -2344 | -1591 |
Capital Expenditures | -188 | -383 | -600 | -787 | -162 |
Other Investing Cash Flow Items, Total | -154 | -201 | -599 | -1557 | -1429 |
Cash From Financing Activities | -3174 | -9058 | -12701 | -19039 | -6972 |
Financing Cash Flow Items | -136 | -312 | -458 | -674 | -225 |
Total Cash Dividends Paid | -2322 | -4632 | -6947 | -9261 | -2526 |
Issuance (Retirement) of Stock, Net | -716 | -653 | -634 | -690 | -1342 |
Foreign Exchange Effects | -55 | -28 | -69 | -97 | 7 |
Net Change in Cash | 1306 | 97 | 3733 | 1297 | -3648 |
Issuance (Retirement) of Debt, Net | -3461 | -4662 | -8414 | -2879 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7767 | 155214623 | 2427842 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.8451 | 85684892 | 580768 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.3815 | 77486317 | 366695 | 2022-09-30 | LOW |
Capital International Investors | Investment Advisor | 2.5913 | 45827258 | 2672137 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 2.3615 | 41762005 | 1514157 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 2.0466 | 36193102 | 9896885 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.913 | 33830501 | 3749074 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.2483 | 22075712 | -8732086 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0162 | 17970964 | -182537 | 2021-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.9843 | 17407862 | 567443 | 2022-09-30 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.9163 | 16204586 | -101931 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.8355 | 14774796 | -2409811 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7296 | 12903350 | -230939 | 2022-09-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.713 | 12608487 | 220531 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.6939 | 12271066 | -259294 | 2022-09-30 | LOW |
Nuveen LLC | Pension Fund | 0.6932 | 12258461 | -722546 | 2022-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6742 | 11923937 | -987224 | 2022-09-30 | LOW |
BofA Global Research (US) | Research Firm | 0.6476 | 11452674 | -853282 | 2022-09-30 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5887 | 10410769 | -248975 | 2022-09-30 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.5451 | 9639899 | -260891 | 2022-09-30 | LOW |
为什么选择 Capital.com?让我们的数字来说话。
Capital.com Group交易計算器
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
AbbVie Company profile
关于 AbbVie Inc
艾伯维公司(AbbVie)是一家基于研究的生物制药公司。 该公司从事药品和疗法的研发、生产、商业化和销售。 艾伯维公司提供各种治疗类别的产品,包括免疫学产品,其中包括Humira、Skyrizi和Rinvoq;肿瘤学产品包括Imbruvica和Venclexta;美容学产品包括Botox Cosmetic、Juvederm Collection和其他美容学。 神经科学产品,如Botox Therapeutic、Vraylar、Duopa和Duodopa以及Ubrelvy;眼部护理产品包括Lumigan、Alphagan和Restasis;妇女健康产品包括Loestrin、Orilissa和其他妇女健康;以及其他关键产品,包括Mavyret、Creon、Lupron、Linzess和Synthroid。 公司的产品在全球范围内从AbbVie拥有的分销中心和公共仓库直接销售给批发商、分销商、政府机构、医疗保健机构和独立零售商。
Industry: | Pharmaceuticals (NEC) |
1 N Waukegan Rd
NORTH CHICAGO
ILLINOIS 60064
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球485,000万多名交易者的一份子,选择利用Capital.com进行交易吧。